NICOLE MASSEY: Open Payments
NPI 1033666276 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 33 payments from 13 companies in 2025. Trend: 2023 $789 · 2024 $802 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $205 |
| Boston Scientific Corporation | 3 | $98 |
| PFIZER INC. | 4 | $82 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $39 |
| Amgen Inc. | 2 | $27 |
| SCPHARMACEUTICALS INC. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: Wegovy, WATCHMAN FLX, VYNDAQEL, Kerendia, AMVUTTRA, LifeVest, LEQVIO, REPATHA.
Industry payments across AL — which companies pay providers there.
